Recent study suggests that resistin could be a key biomarker and therapeutic target in pulmonary arterial hypertension, “Respiratory Research”, June 6, 2024
The findings of study which aimed to evaluate the potential for using resistin as a genetic and biological marker for disease severity and survival in pulmonary arterial hypertension were published on June 6, 2024 in “Pulmonary Research”. Resistin is an adipose-derived hormone (similar to a cytokine). The researchers collected biospecimens, clinical, and genetic data for 1.121 adults […]